The US Food and Drug Administration (FDA) will allow Quest Diagnostics' Focus Diagnostics division to add a genital swab test to its Simplexa herpes simplex virus (HSV) type 1 and 2 direct molecular ...
Background. Current estimates of the prevalence of herpes simplex virus-2 (HSV-2) among HIV-infected individuals range from 70% to 90% in the developing world. In the United States, researchers report ...
IRVINE, CA, AND MIAMI, FL, MARCH 8, 2010 - Molecular dermatology research and development innovator DermaGenoma, Inc. today released The HerpesDX Genetic Test for Frequent Genital Herpes. The new ...
Please provide your email address to receive an email when new articles are posted on . One of the most contentious topics in the treatment of differences of sex development is early genital surgery ...